Invention Grant
- Patent Title: Anti-metastatic agents predicated upon polyamine macrocyclic conjugates
- Patent Title (中): 基于聚胺大环偶联物的抗转移剂
-
Application No.: US14388851Application Date: 2013-03-13
-
Publication No.: US09266815B2Publication Date: 2016-02-23
- Inventor: Otto Phanstiel, IV , Aaron Muth
- Applicant: Otto Phanstiel, IV , Aaron Muth
- Applicant Address: US FL Orlando
- Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee: University of Central Florida Research Foundation, Inc.
- Current Assignee Address: US FL Orlando
- Agency: Beusse, Wolter, Sanks & Maire, PLLC
- Agent Timothy H. Van Dyke
- International Application: PCT/US2013/031073 WO 20130313
- International Announcement: WO2013/148219 WO 20131003
- Main IPC: C07C211/17
- IPC: C07C211/17 ; A61K31/132 ; A61K45/06 ; C07C211/36
Abstract:
Disclosed herein are novel motuporamine compounds that act as anti-metastatic agents with low toxicity and high anti-migration activity. The non-toxic, anti-metastatic agents may be given to patients with potential or actual metastatic cancers, such as pancreatic cancers, alone in combination with known and/or new therapies to help block the growth and spread of tumor(s).
Public/Granted literature
- US20150057361A1 ANTI-METASTATIC AGENTS PREDICATED UPON POLYAMINE MACROCYCLIC CONJUGATES Public/Granted day:2015-02-26
Information query
